Your browser doesn't support javascript.
Nanomedicine in oncology: Tiny particles, huge potential
HEM/ONC Today ; 23(8):1-14, 2022.
Article in English | ProQuest Central | ID: covidwho-1970323
ABSTRACT
NBTXR3 is designed to destroy tumors and trigger the immune system for local tumor control and treatment, and is used to strengthen the effect of radiation therapy. [...]it provides a strategy that can deliver therapeutic agents to immune cells more effectively - a 'super shuttle,' per se," she said. A drug will hit the soluble form of a target of interest, but it's also going to hit membrane forms that perform vital regulatory functions, leading to toxicity"' Cancer cells with high levels of PDL1 inhibit the immune system from attacking tumors, allowing them to progress. Kim also discussed previous research into quantum dots, nanocrystals that give off an array of very bright colors depending on the crystal size.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: ONC Today Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: ONC Today Year: 2022 Document Type: Article